Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
JAMA
    May 2021
  1. ADLER AI, Latimer NR
    Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
    JAMA. 2021;325:2110-2111.
    >> Share

  2. DU F, Yuan P
    Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer.
    JAMA. 2021;325:1791-1792.
    >> Share

  3. CHAKRABARTI D, Akhtar N, Kumar V
    Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer.
    JAMA. 2021;325:1792-1793.
    >> Share

  4. BI XW, Hua X, Yuan ZY
    Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer-Reply.
    JAMA. 2021;325:1793.
    >> Share

  5. JATOI I, Kemp Z
    Surgery for Breast Cancer Prevention.
    JAMA. 2021;325:1804.
    >> Share

  6. JATOI I, Kemp Z
    Risk-Reducing Mastectomy.
    JAMA. 2021;325:1781-1782.
    >> Share

    February 2021
  7. MOURAD MS
    Donning and Doffing.
    JAMA. 2021;325:536.
    >> Share

    December 2020
  8. PARSONS HA, Burstein HJ
    Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations.
    JAMA. 2020 Dec 10. pii: 2774294. doi: 10.1001/jama.2020.23371.
    >> Share

  9. WANG X, Wang SS, Huang H, Cai L, et al
    Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Cli
    JAMA. 2020 Dec 10. pii: 2774295. doi: 10.1001/jama.2020.23370.
    >> Share

    November 2020
  10. SLOMSKI A
    Long-term Mortality Outcomes in Early Breast Cancer Screening Trial.
    JAMA. 2020;324:2020.
    >> Share

    September 2020
  11. HAMPTON T
    RNA Aptamers Deliver Chemotherapy Directly to Tumors.
    JAMA. 2020;324:829.
    >> Share

    August 2020
  12. VOELKER R
    Breast Cancer Drug Can Be Given at Home or in the Clinic.
    JAMA. 2020;324:433.
    >> Share

    July 2020
  13. CHLEBOWSKI RT, Anderson GL, Aragaki AK, Manson JE, et al
    Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
    JAMA. 2020;324:369-380.
    >> Share

  14. KURIAN AW, Bernhisel R, Stefanick ML
    Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women-Reply.
    JAMA. 2020;324:397-398.
    >> Share

  15. FOSTIRA F, Kalfakakou D, Konstantopoulou I
    Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women.
    JAMA. 2020;324:397.
    >> Share

  16. MINAMI CA, Freedman RA
    Menopausal Hormone Therapy and Long-term Breast Cancer Risk: Further Data From the Women's Health Initiative Trials.
    JAMA. 2020;324:347-349.
    >> Share

  17. GRAHAM D, DiNome ML, Ganz PA
    Breast Cancer Risk-Reducing Medications.
    JAMA. 2020;324:310.
    >> Share

  18. SHIEH Y, Tice JA
    Medications for Primary Prevention of Breast Cancer.
    JAMA. 2020;324:291-292.
    >> Share

    June 2020
  19. VOELKER R
    Triple-Negative Breast Cancer Drug Receives Approval.
    JAMA. 2020;323:2122.
    >> Share

    March 2020
  20. RUBIN R
    White Blood Cells Might Provide Clues to Breast Cancer Risk.
    JAMA. 2020;323:1123.
    >> Share

  21. KURIAN AW, Bernhisel R, Larson K, Caswell-Jin JL, et al
    Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer.
    JAMA. 2020;323:995-997.
    >> Share

    February 2020
  22. COMSTOCK CE, Gatsonis C, Newstead GM, Snyder BS, et al
    Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    JAMA. 2020;323:746-756.
    >> Share

  23. TOSTESON ANA
    An Abbreviated MRI Protocol for Breast Cancer Screening in Women With Dense Breasts: Promising Results, but Further Evaluation Required Prior to Widespread Implementation.
    JAMA. 2020;323:719-721.
    >> Share

  24. QUAGLIARELLO V
    Tiny Branches.
    JAMA. 2020;323:711-712.
    >> Share

  25. COMSTOCK CE, Gatsonis C, Newstead GM, Snyder BS, et al
    Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    JAMA. 2020;323:746-756.
    >> Share

  26. ABBASI J
    Artificial Intelligence Improves Breast Cancer Screening in Study.
    JAMA. 2020;323:499.
    >> Share

  27. VOELKER R
    Another Targeted Therapy for ERBB2-Positive Breast Cancer.
    JAMA. 2020;323:408.
    >> Share

    January 2020
  28. KRIST AH, Owens DK, Mangione CM
    Recommendations Related to Genetic Testing for Breast Cancer-Reply.
    JAMA. 2020;323:188-189.
    >> Share

  29. PINSKY PF
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:187-188.
    >> Share

  30. DORK T, Park-Simon TW, Hillemanns P
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:188.
    >> Share

  31. SLAVIN SD
    Doctoring and Deportation.
    JAMA. 2020;323:119-120.
    >> Share

    December 2019
  32. FAYANJU OLM
    Hiding in Plain Sight.
    JAMA. 2019;322:2173-2174.
    >> Share

    September 2019
  33. SLOMSKI A
    Adjuvant Therapy for HER2-Positive Breast Cancer.
    JAMA. 2019;322:1134.
    >> Share

  34. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;322:857-867.
    >> Share

  35. NELSON HD, Fu R, Zakher B, Pappas M, et al
    Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;322:868-886.
    >> Share

  36. JIN J
    Medications to Reduce Breast Cancer Risk.
    JAMA. 2019;322:900.
    >> Share

  37. PACE LE, Keating NL
    Medications to Reduce Breast Cancer Risk: Promise and Limitations.
    JAMA. 2019;322:821-823.
    >> Share

    August 2019
  38. IZZO MC, Bronner G, Shields CL
    Rapidly Progressive Vision Loss in a Patient With Breast Cancer.
    JAMA. 2019 Aug 22. pii: 2749078. doi: 10.1001/jama.2019.12691.
    >> Share

  39. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;322:652-665.
    >> Share

  40. NELSON HD, Pappas M, Cantor A, Haney E, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;322:666-685.
    >> Share

  41. JIN J
    Should I Be Tested for BRCA Mutations?
    JAMA. 2019;322:702.
    >> Share

    July 2019
  42. SLOMSKI A
    Preventing Cardiotoxicity Associated With Breast Cancer Therapy.
    JAMA. 2019;322:296.
    >> Share


  43. First PI3K Inhibitor for Breast Cancer.
    JAMA. 2019;322:19.
    >> Share

  44. CHOI JM
    An Unexpected Asset.
    JAMA. 2019;322:29.
    >> Share

    June 2019
  45. KEATING NL, Pace LE
    New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients?
    JAMA. 2019;321:2275-2276.
    >> Share

    May 2019
  46. KERLIKOWSKE K, Miglioretti DL, Vachon CM
    Discussions of Dense Breasts, Breast Cancer Risk, and Screening Choices in 2019.
    JAMA. 2019 May 31. pii: 2735405. doi: 10.1001/jama.2019.6247.
    >> Share

  47. CRANDALL CJ, Livingston E
    Women's Health: A New JAMA Clinical Insights Series.
    JAMA. 2019;321:1676.
    >> Share

  48. POLITE BN, Gluck AR, Brawley OW
    Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
    JAMA. 2019;321:1663-1664.
    >> Share

    April 2019
  49. RUDDY KJ, Ganz PA
    Treatment of Nonmetastatic Breast Cancer.
    JAMA. 2019 Apr 12. pii: 2731086. doi: 10.1001/jama.2019.3927.
    >> Share

  50. VOELKER R
    Quick Uptakes: Taking the Uncertainty Out of Interpreting BRCA Variants.
    JAMA. 2019;321:1340-1341.
    >> Share

    February 2019
  51. SLOMSKI A
    BMI Not a Good Proxy for Breast Cancer Risk.
    JAMA. 2019;321:735.
    >> Share

    January 2019
  52. WAKS AG, Winer EP
    Breast Cancer Treatment: A Review.
    JAMA. 2019;321:288-300.
    >> Share

  53. WAKS AG, Winer EP
    Breast Cancer Treatment.
    JAMA. 2019;321:316.
    >> Share

  54. DOMCHEK SM
    Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion.
    JAMA. 2019;321:27.
    >> Share

    December 2018
  55. SLOMSKI A
    Chemoimmunotherapy for Triple-Negative Breast Cancer.
    JAMA. 2018;320:2521.
    >> Share

  56. HERSHMAN DL, Unger JM, Crew K
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2270-2271.
    >> Share

  57. LIU C, Zhang H, Sun C
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2270.
    >> Share

  58. MAO JJ, Farrar JT
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2269-2270.
    >> Share

    August 2018
  59. LEE GK, Sheckter CC
    Breast Reconstruction Following Breast Cancer Treatment-2018.
    JAMA. 2018 Aug 31. pii: 2701789. doi: 10.1001/jama.2018.12190.
    >> Share

  60. GROSS AL, Blot WJ, Visvanathan K
    BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
    JAMA. 2018;320:597-598.
    >> Share

  61. ABBASI J
    Can Acupuncture Keep Women on Their Breast Cancer Drugs?
    JAMA. 2018 Aug 8. pii: 2696922. doi: 10.1001/jama.2018.11068.
    >> Share

    July 2018
  62. SLOMSKI A
    Many Women With Early Breast Cancer May Not Need Chemotherapy.
    JAMA. 2018;320:332.
    >> Share

  63. HERSHMAN DL, Unger JM, Greenlee H, Capodice JL, et al
    Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2018;320:167-176.
    >> Share

  64. ABBASI J
    Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer.
    JAMA. 2018;320:127.
    >> Share

    June 2018
  65. GILL J, Obley AJ, Prasad V
    Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    JAMA. 2018;319:2377-2378.
    >> Share

  66. PLEVRITIS SK, Berry DA, Mandelblatt JS
    Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply.
    JAMA. 2018;319:2336.
    >> Share

  67. CHEN HH
    Contributions of Screening and Treatment to Mortality From Breast Cancer.
    JAMA. 2018;319:2335-2336.
    >> Share

    May 2018
  68. KEATING NL, Pace LE
    Breast Cancer Screening in 2018: Time for Shared Decision Making.
    JAMA. 2018;319:1814-1815.
    >> Share

    April 2018
  69. BEJNORDI BE, Litjens G, van der Laak JA
    Machine Learning Compared With Pathologist Assessment-Reply.
    JAMA. 2018;319:1726.
    >> Share

  70. VAN SMEDEN M, Van Calster B, Groenwold RHH
    Machine Learning Compared With Pathologist Assessment.
    JAMA. 2018;319:1725-1726.
    >> Share

    March 2018
  71. KATZ SJ, Jagsi R, Morrow M
    Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
    JAMA. 2018;319:1091-1092.
    >> Share

    February 2018
  72. PEACHMAN RR
    Weighing the Risks and Benefits of Hormonal Contraception.
    JAMA. 2018 Feb 28. pii: 2673941. doi: 10.1001/jama.2018.0448.
    >> Share

  73. HENNEMAN JR
    In Shadow and Light-Images of Transformation Through Breast Cancer.
    JAMA. 2018;319:532-534.
    >> Share

    January 2018
  74. BALLMAN KV, McCall LM, Giuliano AE
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
    JAMA. 2018;319:306-307.
    >> Share

  75. UNO H, Hassett MJ, Wei LJ
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.
    JAMA. 2018;319:306.
    >> Share

  76. PLEVRITIS SK, Munoz D, Kurian AW, Stout NK, et al
    Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
    JAMA. 2018;319:154-164.
    >> Share

  77. MANSON JE, Aragaki AK, Rossouw JE
    Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.
    JAMA. 2018;319:193-194.
    >> Share

  78. HICKEY M, McNamara HC, Mishra GD
    Menopausal Estrogen Therapy and Breast Cancer Mortality.
    JAMA. 2018;319:193.
    >> Share

    December 2017
  79. EHTESHAMI BEJNORDI B, Veta M, Johannes van Diest P, van Ginneken B, et al
    Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    JAMA. 2017;318:2199-2210.
    >> Share

  80. GOLDEN JA
    Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.
    JAMA. 2017;318:2184-2186.
    >> Share

    November 2017
  81. ENGELHARDT KE, Barnard C, Bilimoria KY
    Wrong-Site Surgery.
    JAMA. 2017;318:2033-2034.
    >> Share

  82. THOMAS R, Fysh ETH, Smith NA, Lee P, et al
    Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    JAMA. 2017;318:1903-1912.
    >> Share

    September 2017
  83. SLOMSKI A
    Low-Fat Diet Reduces Mortality After Breast Cancer.
    JAMA. 2017;318:1099.
    >> Share

  84. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    >> Share

  85. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    >> Share

  86. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016